Growth Metrics

Biofrontera (BFRI) Receivables - Net (2020 - 2025)

Biofrontera has reported Receivables - Net over the past 6 years, most recently at $7.3 million for Q4 2025.

  • For Q4 2025, Receivables - Net rose 37.18% year-over-year to $7.3 million; the TTM value through Dec 2025 reached $7.3 million, up 37.18%, while the annual FY2025 figure was $7.3 million, 37.18% up from the prior year.
  • Receivables - Net for Q4 2025 was $7.3 million at Biofrontera, up from $3.0 million in the prior quarter.
  • Over five years, Receivables - Net peaked at $7.3 million in Q4 2025 and troughed at $1.6 million in Q3 2022.
  • A 5-year average of $3.8 million and a median of $3.8 million in 2021 define the central range for Receivables - Net.
  • Biggest five-year swings in Receivables - Net: surged 142.83% in 2023 and later crashed 38.55% in 2025.
  • Year by year, Receivables - Net stood at $3.8 million in 2021, then dropped by 0.95% to $3.7 million in 2022, then skyrocketed by 37.73% to $5.2 million in 2023, then rose by 2.96% to $5.3 million in 2024, then soared by 37.18% to $7.3 million in 2025.
  • Business Quant data shows Receivables - Net for BFRI at $7.3 million in Q4 2025, $3.0 million in Q3 2025, and $4.0 million in Q2 2025.